Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

466 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antiangiogenic gene therapy.
Folkman J. Folkman J. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9064-6. doi: 10.1073/pnas.95.16.9064. Proc Natl Acad Sci U S A. 1998. PMID: 9689032 Free PMC article. No abstract available.
Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition.
Sunshine SB, Dallabrida SM, Durand E, Ismail NS, Bazinet L, Birsner AE, Sohn R, Ikeda S, Pu WT, Kulke MH, Javaherian K, Zurakowski D, Folkman JM, Rupnick M. Sunshine SB, et al. Among authors: folkman jm. Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11306-11. doi: 10.1073/pnas.1203275109. Epub 2012 Jun 25. Proc Natl Acad Sci U S A. 2012. PMID: 22733742 Free PMC article.
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.
Eder JP Jr, Supko JG, Clark JW, Puchalski TA, Garcia-Carbonero R, Ryan DP, Shulman LN, Proper J, Kirvan M, Rattner B, Connors S, Keogan MT, Janicek MJ, Fogler WE, Schnipper L, Kinchla N, Sidor C, Phillips E, Folkman J, Kufe DW. Eder JP Jr, et al. Among authors: folkman j. J Clin Oncol. 2002 Sep 15;20(18):3772-84. doi: 10.1200/JCO.2002.02.082. J Clin Oncol. 2002. PMID: 12228197 Clinical Trial.
466 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page